Page 20 - Programa Educacional Congres SEHH-SETH 2017

❯ Bibliography
1. Basso K, Dalla-Favera R. Germinal centres and B cell lymphomagenesis. Nat Rev Immunol. 2015;15(3):172-84.
2. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identi ed by gene expression pro ling. Nature. 2000;403(6769):503-11.
3. Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Küppers R, Dalla-Favera R. Hypermutation of multiple proto-oncogenes in B-cell dif- fuse large-cell lymphomas. Nature. 2001;412(6844):341-6.
4. Schmitz R, Ceribelli M, Pittaluga S, Wright G, Staudt LM. Oncogenic mecha- nisms in Burkitt lymphoma. Cold Spring Harb Perspect Med. 2014;4(2).
5. Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011;476(7360):298-303.
6. Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A, et al. Analy- sis of the coding genome of diffuse large B-cell lymphoma. Nat Genet. 2011;43(9):830-7.
7. Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB, et al. Genetics of follicular lymphoma transformation. Cell Rep. 2014;6(1):130-40.
8. Basso K, Dalla-Favera R. Roles of BCL6 in normal and transformed germinal center B cells. Immunol Rev. 2012;247(1):172-83.
9. Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature. 2011;471(7337):189-95.
10. Ying CY, Dominguez-Sola D, Fabi M, Lorenz IC, Hussein S, Bansal M, et al. MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma. Nat Immunol. 2013;14(10):1084-92.
11. Schneider C,Kon N,Amadori L,Shen Q,Schwartz FH,Tischler B,et al.FBXO11
inactivation leads to abnormal germinal-center formation and lymphoprolif-
erative disease. Blood. 2016;128(5):660-6.
12. Zhang J, Dominguez-Sola D, Hussein S, Lee JE, Holmes AB, Bansal M, et al.
Disruption of KMT2D perturbs germinal center B cell development and pro-
motes lymphomagenesis. Nat Med. 2015;21(10):1190-8.
13. Zhang J, Vlasevska S, Wells VA, Nataraj S, Holmes AB, Duval R, et al. The CREBBP Acetyltransferase Is a Haploinsuf cient Tumor Suppressor in B-cell
Lymphoma. Cancer Discov. 2017;7(3):322-37.
14. Challa-Malladi M, Lieu YK, Califano O, Holmes AB, Bhagat G, Murty VV, et al.
Combined genetic inactivation of beta2-Microglobulin and CD58 reveals fre- quent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell. 2011;20(6):728-40.
15. Beguelin W, Popovic R, Teater M, Jiang Y, Bunting KL, Rosen M, et al. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell. 2013;23(5):677-92.
16. Muppidi JR, Schmitz R, Green JA, Xiao W, Larsen AB, Braun SE, et al. Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma. Nature. 2014;516(7530):254-8.
17. Boice M, Salloum D, Mourcin F, Sanghvi V, Amin R, Oricchio E, et al. Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modi ed CAR-T Cells. Cell. 2016;167(2):405-18.e413.
18. Davis RE, Brown KD, Siebenlist U, Staudt LM. Constitutive nuclear factor kap- paB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med. 2001;194(12):1861-74.
19. Mandelbaum J, Bhagat G,Tang H, Mo T, Brahmachary M, Shen Q, et al. BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like dif- fuse large B cell lymphoma. Cancer Cell. 2010;18(6):568-79.
20. Pasqualucci L, Compagno M, Houldsworth J, Monti S, Grunn A, Nandula SV, et al. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med. 2006;203(2):311-7.
20
LIX Congreso Nacional SEHH-XXXIII Congreso Nacional SETH / Programa Educacional